(Press-News.org) Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.
Sotagliflozin is a sodium-glucose cotransporter (SGLT) inhibitor. It blocks the function of two proteins, known as SGLT1 and SGLT2, which move glucose and sodium across cell membranes and help control blood sugar levels. Other SGLT2 inhibitors do not as significantly block SGLT1.
The study, published February 14 in The Lancet Diabetes & Endocrinology, is the first to show that an SGLT inhibitor has these unique cardiovascular benefits. The results mean that sotagliflozin could become more widely used to reduce the risk of deadly cardiovascular events globally.
“These results demonstrate a new mechanism of action—combined blockade with sotagliflozin of the SGLT1 receptors (found in the kidney, gut, heart, and brain) and SGLT2 receptors (found in the kidney)—to reduce heart attack and stroke risk,” says study chair Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, Director of Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai. “The benefits seen here are distinct from those seen with the other very popular SGLT2 inhibitors in widespread clinical use for diabetes, heart failure, and kidney disease.”
The randomized, multicenter trial, known as SCORED, analyzed the ability of sotagliflozin to reduce the risks of life-threatening cardiovascular outcomes. Researchers enrolled 10,584 patients with chronic kidney disease, type 2 diabetes, and additional cardiovascular risk factors; randomly assigned them to sotagliflozin or placebo; and followed them for an average of 16 months. Patients in the sotagliflozin group had a 23 percent reduction in the rate of heart attacks, strokes, and deaths from such cardiovascular causes compared with the placebo group.
“Physicians now have a new option to reduce global cardiovascular risk such as heart failure, progression of kidney disease, heart attack, and stroke in patients with either heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors,” adds Dr. Bhatt. “This drug was approved to reduce the risk of deaths from cardiovascular causes, hospitalizations for heart failure, and urgent heart failure visits for patients with either heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors. These important, new data show that it additionally reduces the risk of heart attacks and strokes, and we could see more widespread use as a result.”
Lexicon Pharmaceuticals funded the trial. The Icahn School of Medicine at Mount Sinai receives research funding from Lexicon Pharmaceuticals for Dr. Bhatt’s role as Chair of the SCORED trial.
Mount Sinai Is a World Leader in Cardiology and Heart Surgery
Mount Sinai Fuster Heart Hospital at The Mount Sinai Hospital ranks No. 4 nationally for cardiology, heart, and vascular surgery, according to U.S. News & World Report®. It also ranks No. 1 in New York according to Newsweek’s “The World’s Best Specialized Hospitals.”
It is part of Mount Sinai Health System, which is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. We advance medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 9,000 primary and specialty care physicians; 11 free-standing joint-venture centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 39 multidisciplinary research, educational, and clinical institutes. Hospitals within the Health System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report's® “Best Hospitals” Honor Roll for 2024-2025.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
END
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
2025-02-15
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Researchers discover how opsin 3, a light-sensitive brain protein, regulates food consumption in mice
2025-02-14
PROVIDENCE, R.I. [Brown University] — Scientists discovered years ago that the hypothalamus — which helps to manage body temperature, hunger, sex drive, sleep and more — includes neurons that express the protein opsin 3 (OPN3). Far less clear, however, was what this light-sensing protein does so deep inside the brain.
A study published in PNAS suggests that OPN3 plays an important role in regulating food consumption.
“Our results uncover a mechanism by which the nonvisual opsin ...
New blood test could improve Alzheimer’s Disease diagnosis, research finds
2025-02-14
New blood test could improve Alzheimer’s Disease diagnosis, research finds
Up to half of all people living with Alzheimer’s Disease in Ireland remain undiagnosed. Now, a new blood test may have the potential to transform patient care, allowing for better diagnosis, earlier interventions and more targeted treatments.
Researchers at Trinity College Dublin, the Tallaght Institute of Memory and Cognition and St James’s Hospital, Dublin are exploring the ability of a new blood test, plasma p-tau217, to detect Alzheimer’s Disease (AD). This test could potentially replace the current diagnostic method, a lumbar puncture/spinal tap (which ...
Outstanding Cal Poly public health faculty member and global health advocate among first Faculty Excellence Award honorees
2025-02-14
Cal Poly Assistant Professor Joni Roberts has been chosen, with two additional university faculty members, as the first Cal Poly Faculty Excellence Award honorees.
The inaugural Faculty Excellence Award — an honor recognizing outstanding contributions in teaching, research and service — is administered by the Office of the Provost and funded by generous donor contributions. The award reflects Cal Poly’s commitment to academic excellence and its Learn by Doing philosophy.
The ...
Trees might need our help to survive climate change, CSU study finds
2025-02-14
A new Colorado State University study of the interior U.S. West has found that tree ranges are generally contracting in response to climate change but not expanding into cooler, wetter climates – suggesting that forests are not regenerating fast enough to keep pace with climate change, wildfire, insects and disease.
As the climate becomes too warm for trees in certain places, tree ranges have been expected to shift toward more ideal conditions. The study analyzed national forest inventory data for more than 25,000 plots in ...
Terabytes of data in a millimeter crystal
2025-02-14
From punch card-operated looms in the 1800s to modern cellphones, if an object has an “on” and an “off” state, it can be used to store information.
In a computer laptop, the binary ones and zeroes are transistors either running at low or high voltage. On a compact disc, the one is a spot where a tiny indented “pit” turns to a flat “land” or vice versa, while a zero is when there’s no change.
Historically, the size of the object making the “ones” and “zeroes” has put a limit on the size of the storage device. But now, University of Chicago Pritzker School of Molecular ...
New technology enhances gravitational-wave detection
2025-02-14
RIVERSIDE, Calif. -- In a paper published earlier this month in Physical Review Letters, a team of physicists led by Jonathan Richardson of the University of California, Riverside, showcases how new optical technology can extend the detection range of gravitational-wave observatories such as the Laser Interferometer Gravitational-Wave Observatory, or LIGO, and pave the way for future observatories.
Since 2015, observatories like LIGO have opened a new window on the universe. Plans for future upgrades to the 4-kilometer LIGO detectors and the construction of a next-generation 40-kilometer observatory, Cosmic Explorer, aim to push the gravitational-wave ...
Gene therapy for rare epilepsy shows promise in mice
2025-02-14
Dravet syndrome and other developmental epileptic encephalopathies are rare but devastating conditions that cause a host of symptoms in children, including seizures, intellectual disability, and even sudden death.
Most cases are caused by a genetic mutation; Dravet syndrome in particular is most often caused by variants in the sodium channel gene SCN1A.
Recent research from Michigan Medicine takes aim at another variant in SCN1B, which causes an even more severe form of DEE.
Mice without the SCN1B gene experience seizures and 100 percent mortality just ...
Scientists use distant sensor to monitor American Samoa earthquake swarm
2025-02-14
In late July to October 2022, residents of the Manu’a Islands in American Samoa felt the earth shake several times a day, raising concerns of an imminent volcanic eruption or tsunami.
An earthquake catalog for the area turned up nothing, because the islands lacked a seismic monitoring network that could measure the shaking and aid seismologists in their search for the source of the earthquake swarm.
But the residents of the Taʻū, Ofu, and Olosega islands needed answers, so Clara Yoon of the ...
New study explains how antidepressants can protect against infections and sepsis
2025-02-14
LA JOLLA (February 14, 2025)—Antidepressants like Prozac are commonly prescribed to treat mental health disorders, but new research suggests they could also protect against serious infections and life-threatening sepsis. Scientists at the Salk Institute have now uncovered how the drugs are able to regulate the immune system and defend against infectious disease—insights that could lead to a new generation of life-saving treatments and enhance global preparedness for future pandemics.
The Salk study follows recent findings that users of selective ...
Research reveals how Earth got its ice caps
2025-02-14
University of Leeds news
Embargoed until 14 February 2025 (19:00 GMT)
---
The cool conditions which have allowed ice caps to form on Earth are rare events in the planet’s history and require many complex processes working at once, according to new research.
A team of scientists led by the University of Leeds investigated why Earth has existed in what is known as a 'greenhouse' state without ice caps for much of its history, and why the conditions we are living in now are so rare.
They found ...